AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS
Authors: DEMETER LM MEEHAN PM MORSE G FISCHL MA PARA M POWDERLY W LEEDOM J HOLDENWILTSE J GREISBERGER C WOOD K TIMPONE J WATHEN LK NEVIN T RESNICK L BATTS DH REICHMAN RC
Citation: Lm. Demeter et al., PHASE-I STUDY OF ATEVIRDINE MESYLATE (U-87201E) MONOTHERAPY IN HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 19(2), 1998, pp. 135-144
PERCEPTIONS OF DO-NOT-RESUSCITATE ORDERS
Authors: RESNICK L COWART ME KUBRIN A
Citation: L. Resnick et al., PERCEPTIONS OF DO-NOT-RESUSCITATE ORDERS, Social work in health care, 26(4), 1998, pp. 1-21
EXECUTIVE MOMS
Authors: MASTONY C SERLIN M SIEBERT M JOHNSON B RESNICK L BERNER M RAVIT B ILITCH D LAZARUS S KNAPP EM BARTZ C
Citation: C. Mastony et al., EXECUTIVE MOMS, Forbes, 162(1), 1998, pp. 20
QUANTITATIVE-ANALYSIS OF DELOCALIZATION IN THE VICINITY OF THE METAL-INSULATOR-TRANSITION IN DOPED SEMICONDUCTORS
Authors: SHLIMAK I KAVEH M USSYSHKIN R GINODMAN V RESNICK L GANTMAKHER VF
Citation: I. Shlimak et al., QUANTITATIVE-ANALYSIS OF DELOCALIZATION IN THE VICINITY OF THE METAL-INSULATOR-TRANSITION IN DOPED SEMICONDUCTORS, Journal of physics. Condensed matter, 9(45), 1997, pp. 9873-9880
UNIFICATION OF THE METAL-INSULATOR TRANSITIONS DRIVEN BY THE IMPURITYCONCENTRATION AND BY THE MAGNETIC-FIELD IN ARSENIC-DOPED GERMANIUM
Authors: SHLIMAK I KAVEH M USSYSHKIN R GINODMAN V RESNICK L
Citation: I. Shlimak et al., UNIFICATION OF THE METAL-INSULATOR TRANSITIONS DRIVEN BY THE IMPURITYCONCENTRATION AND BY THE MAGNETIC-FIELD IN ARSENIC-DOPED GERMANIUM, Physical review. B, Condensed matter, 55(3), 1997, pp. 1303-1305
DETERMINATION OF THE CRITICAL CONDUCTIVITY EXPONENT FOR THE METAL-INSULATOR-TRANSITION AT NONZERO TEMPERATURES - UNIVERSALITY OF THE TRANSITION - REPLY
Authors: SHLIMAK I KAVEH M USSYSHKIN R GINODMAN V RESNICK L
Citation: I. Shlimak et al., DETERMINATION OF THE CRITICAL CONDUCTIVITY EXPONENT FOR THE METAL-INSULATOR-TRANSITION AT NONZERO TEMPERATURES - UNIVERSALITY OF THE TRANSITION - REPLY, Physical review letters, 78(20), 1997, pp. 3978-3978
COMPREHENSIVE RISK REDUCTION NUTRITION PROGRAM LOWERS HOMOCYSTEINE LEVELS IN PATIENTS AT RISK FOR CARDIOVASCULAR-DISEASE
Authors: CHAIT A RESNICK L
Citation: A. Chait et L. Resnick, COMPREHENSIVE RISK REDUCTION NUTRITION PROGRAM LOWERS HOMOCYSTEINE LEVELS IN PATIENTS AT RISK FOR CARDIOVASCULAR-DISEASE, Journal of investigative medicine, 44(3), 1996, pp. 285-285
DIAGNOSIS OF PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY MEANS OF A COMMERCIALLY AVAILABLE POLYMERASE CHAIN-REACTION GENE AMPLIFICATION
Authors: NELSON RP PRICE LJ HALSEY AB GRAVEN SN RESNICK L DAY NK LOCKEY RF GOOD RA
Citation: Rp. Nelson et al., DIAGNOSIS OF PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION BY MEANS OF A COMMERCIALLY AVAILABLE POLYMERASE CHAIN-REACTION GENE AMPLIFICATION, Archives of pediatrics & adolescent medicine, 150(1), 1996, pp. 40-45
INTRACELLULAR FREE MAGNESIUM (MGI) AS A DETERMINANT OF INSULIN ACTION- COMPARISON TO IGF-1 AND VANADATE
Authors: BARBAGALLO M DOMINGUEZ L RESNICK L
Citation: M. Barbagallo et al., INTRACELLULAR FREE MAGNESIUM (MGI) AS A DETERMINANT OF INSULIN ACTION- COMPARISON TO IGF-1 AND VANADATE, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1891-1891
DETERMINATION OF THE CRITICAL CONDUCTIVITY EXPONENT FOR THE METAL-INSULATOR-TRANSITION AT NONZERO TEMPERATURES - UNIVERSALITY OF THE TRANSITION
Authors: SHLIMAK I KAVEH M USSYSHKIN R GINODMAN V RESNICK L
Citation: I. Shlimak et al., DETERMINATION OF THE CRITICAL CONDUCTIVITY EXPONENT FOR THE METAL-INSULATOR-TRANSITION AT NONZERO TEMPERATURES - UNIVERSALITY OF THE TRANSITION, Physical review letters, 77(6), 1996, pp. 1103-1106
THE BENZYLTHIO-PYRIMIDINE U-31,355, A POTENT INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE
Authors: ALTHAUS IW CHOU KC LEMAY RJ FRANKS KM DEIBEL MR KEZDY FJ RESNICK L BUSSO ME SO AG DOWNEY KM ROMERO DL THOMAS RC ARISTOFF PA TARPLEY WG REUSSER F
Citation: Iw. Althaus et al., THE BENZYLTHIO-PYRIMIDINE U-31,355, A POTENT INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE, Biochemical pharmacology, 51(6), 1996, pp. 743-750
COMBINATION THERAPY WITH RECOMBINANT HUMAN SOLUBLE CD4-IMMUNOGLOBULIN-G AND ZIDOVUDINE IN PATIENTS WITH HIV-INFECTION - A PHASE-I STUDY
Authors: MENG TC FISCHL MA CHEESEMAN SH SPECTOR SA RESNICK L BOOTA A PETRAKIS T WRIGHT B RICHMAN DD
Citation: Tc. Meng et al., COMBINATION THERAPY WITH RECOMBINANT HUMAN SOLUBLE CD4-IMMUNOGLOBULIN-G AND ZIDOVUDINE IN PATIENTS WITH HIV-INFECTION - A PHASE-I STUDY, Journal of acquired immune deficiency syndromes and human retrovirology, 8(2), 1995, pp. 152-160
DETERMINATION OF THE IMPURITY CONCENTRATION IN HEAVILY-DOPED INHOMOGENEOUS SEMICONDUCTORS FROM THE MEASUREMENT OF THE LOW-TEMPERATURE CONDUCTIVITY
Authors: SHLIMAK I USSYSHKIN R RESNICK L GINODMAN V
Citation: I. Shlimak et al., DETERMINATION OF THE IMPURITY CONCENTRATION IN HEAVILY-DOPED INHOMOGENEOUS SEMICONDUCTORS FROM THE MEASUREMENT OF THE LOW-TEMPERATURE CONDUCTIVITY, Applied physics A: Materials science & processing, 61(2), 1995, pp. 115-118
P-31-NMR SPECTROSCOPIC STUDIES OF ORAL GLUCOSE LOADING AND IN-SITU SKELETAL-MUSCLE ION CONTENT IN ESSENTIAL-HYPERTENSION
Authors: RESNICK L BARDICEF O BARBAGALLO M MILITIANU D CUNNINGS A EVELHOCH J
Citation: L. Resnick et al., P-31-NMR SPECTROSCOPIC STUDIES OF ORAL GLUCOSE LOADING AND IN-SITU SKELETAL-MUSCLE ION CONTENT IN ESSENTIAL-HYPERTENSION, Hypertension, 26(3), 1995, pp. 552-552
THE FIRST TOTAL SYNTHESIS OF A PYRIPYROPENE-TYPE ACAT INHIBITOR, (+ -)-GERI-BP001/
Authors: PARKER KA RESNICK L
Citation: Ka. Parker et L. Resnick, THE FIRST TOTAL SYNTHESIS OF A PYRIPYROPENE-TYPE ACAT INHIBITOR, (+ -)-GERI-BP001/, Journal of organic chemistry, 60(17), 1995, pp. 5726-5728
PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: REICHMAN RC MORSE GD DEMETER LM RESNICK L BASSIAKOS Y FISCHL M PARA M POWDERLY W LEEDOM J GREISBERGER C NEVIN T WOOD K MEEHAN PM GEHEB H COX S BATTS D TIMPONE J SLACK A ROYAL M QUESADA NR GEISELER PJ STARK N NEIDIG J HILL M
Citation: Rc. Reichman et al., PHASE-I STUDY OF ATEVIRDINE, A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR, IN COMBINATION WITH ZIDOVUDINE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 171(2), 1995, pp. 297-304
WHERE IN THE WORLD ARE WORLD-CLASS STANDARDS
Authors: RESNICK L NOLAN K
Citation: L. Resnick et K. Nolan, WHERE IN THE WORLD ARE WORLD-CLASS STANDARDS, Educational leadership, 52(6), 1995, pp. 6-10
RESISTANCE TO AZT AND DDC DURING LONG-TERM COMBINATION THERAPY IN PATIENTS WITH ADVANCED INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: RICHMAN DD MENG TC SPECTOR SA FISCHL MA RESNICK L LAI SH
Citation: Dd. Richman et al., RESISTANCE TO AZT AND DDC DURING LONG-TERM COMBINATION THERAPY IN PATIENTS WITH ADVANCED INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 135-138
THE SAFETY AND EFFICACY OF COMBINATION N-BUTYL-DEOXYNOJIRIMYCIN (SC-48334) AND ZIDOVUDINE IN PATIENTS WITH HIV-1 INFECTION AND 200-500 CD4 CELLS MM(3)/
Authors: FISCHL MA RESNICK L COOMBS R KREMER AB POTTAGE JC FASS SJ FIFE KH POWDERLY WG COLLIER AC ASPINALL RL SMITH SL KOWALSKI KG WALLEMARK CB
Citation: Ma. Fischl et al., THE SAFETY AND EFFICACY OF COMBINATION N-BUTYL-DEOXYNOJIRIMYCIN (SC-48334) AND ZIDOVUDINE IN PATIENTS WITH HIV-1 INFECTION AND 200-500 CD4 CELLS MM(3)/, Journal of acquired immune deficiency syndromes, 7(2), 1994, pp. 139-147
NOVEL METHOD TO DETECT TRANSCRIPTIONALLY ACTIVE HIV PARTICLES
Authors: BUSSO M RESNICK L
Citation: M. Busso et L. Resnick, NOVEL METHOD TO DETECT TRANSCRIPTIONALLY ACTIVE HIV PARTICLES, AIDS research and human retroviruses, 10, 1994, pp. 190000068-190000068
CEREBROSPINAL-FLUID P24 ANTIGEN LEVELS AND INTRATHECAL IMMUNOGLOBULIN-G SYNTHESIS ARE ASSOCIATED WITH COGNITIVE DISEASE SEVERITY IN HIV-1
Authors: SINGER EJ SYNDULKO K FAHYCHANDON BN SHAPSHAK P RESNICK L SCHMID P CONRAD AJ TOURTELLOTTE WW
Citation: Ej. Singer et al., CEREBROSPINAL-FLUID P24 ANTIGEN LEVELS AND INTRATHECAL IMMUNOGLOBULIN-G SYNTHESIS ARE ASSOCIATED WITH COGNITIVE DISEASE SEVERITY IN HIV-1, AIDS, 8(2), 1994, pp. 197-204
DEVELOPMENT OF AN ASSAY THAT DETECTS TRANSCRIPTIONALLY COMPETENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE ONE PARTICLES
Authors: BUSSO M RESNICK L
Citation: M. Busso et L. Resnick, DEVELOPMENT OF AN ASSAY THAT DETECTS TRANSCRIPTIONALLY COMPETENT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE ONE PARTICLES, Journal of virological methods, 47(1-2), 1994, pp. 129-139
THE EPSTEIN-BARR-VIRUS EBNA-2 GENE IN ORAL HAIRY LEUKOPLAKIA - STRAINVARIATION, GENETIC-RECOMBINATION, AND TRANSCRIPTIONAL EXPRESSION
Authors: WALLING DM PERKINS AG WEBSTERCYRIAQUE J RESNICK L RAABTRAUB N
Citation: Dm. Walling et al., THE EPSTEIN-BARR-VIRUS EBNA-2 GENE IN ORAL HAIRY LEUKOPLAKIA - STRAINVARIATION, GENETIC-RECOMBINATION, AND TRANSCRIPTIONAL EXPRESSION, Journal of virology, 68(12), 1994, pp. 7918-7926
DISCOVERY, SYNTHESIS, AND BIOACTIVITY OF BIS(HETEROARYL)PIPERAZINES .1. A NOVEL CLASS OF NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS
Authors: ROMERO DL MORGE RA BILES C BERRIOSPENA TN MAY PD PALMER JR JOHNSON PD SMITH HW BUSSO M TAN CK VOORMAN RL REUSSER F ALTHAUS IW DOWNEY KM SO AG RESNICK L TARPLEY WG ARISTOFF PA
Citation: Dl. Romero et al., DISCOVERY, SYNTHESIS, AND BIOACTIVITY OF BIS(HETEROARYL)PIPERAZINES .1. A NOVEL CLASS OF NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITORS, Journal of medicinal chemistry, 37(7), 1994, pp. 999-1014
HUMAN PAROTID PROLINE-RICH PROTEIN BINDS TO HIV COAT GLYCOPROTEIN
Authors: ROBINOVITCH MR IVERSEN JM RESNICK L OPPENHEIM FG LAMKIN MS
Citation: Mr. Robinovitch et al., HUMAN PAROTID PROLINE-RICH PROTEIN BINDS TO HIV COAT GLYCOPROTEIN, Journal of dental research, 73, 1994, pp. 150-150
Risultati: 1-25 | 26-32